Global Lanreotide Drugs Market Growth 2022-2028
- LP 4871620
- 76 Pages
- February 2022
- Pharmaceuticals
The United States Lanreotide Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lanreotide Drugs market, reaching US$ million by the year 2028. As for the Europe Lanreotide Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lanreotide Drugs players cover IPSEN, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lanreotide Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
60 mg
90 mg
120 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
IPSEN
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lanreotide Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lanreotide Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lanreotide Drugs by Country/Region, 2017, 2022 & 2028
2.2 Lanreotide Drugs Segment by Type
2.2.1 60 mg
2.2.2 90 mg
2.2.3 120 mg
2.3 Lanreotide Drugs Sales by Type
2.3.1 Global Lanreotide Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Lanreotide Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lanreotide Drugs Sale Price by Type (2017-2022)
2.4 Lanreotide Drugs Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Lanreotide Drugs Sales by Application
2.5.1 Global Lanreotide Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Lanreotide Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lanreotide Drugs Sale Price by Application (2017-2022)
3 Global Lanreotide Drugs by Company
3.1 Global Lanreotide Drugs Breakdown Data by Company
3.1.1 Global Lanreotide Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Lanreotide Drugs Sales Market Share by Company (2020-2022)
3.2 Global Lanreotide Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Lanreotide Drugs Revenue by Company (2020-2022)
3.2.2 Global Lanreotide Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Lanreotide Drugs Sale Price by Company
3.4 Key Manufacturers Lanreotide Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lanreotide Drugs Product Location Distribution
3.4.2 Players Lanreotide Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lanreotide Drugs by Geographic Region
4.1 World Historic Lanreotide Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Lanreotide Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lanreotide Drugs Annual Revenue by Geographic Region
4.2 World Historic Lanreotide Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Lanreotide Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lanreotide Drugs Annual Revenue by Country/Region
4.3 Americas Lanreotide Drugs Sales Growth
4.4 APAC Lanreotide Drugs Sales Growth
4.5 Europe Lanreotide Drugs Sales Growth
4.6 Middle East & Africa Lanreotide Drugs Sales Growth
5 Americas
5.1 Americas Lanreotide Drugs Sales by Country
5.1.1 Americas Lanreotide Drugs Sales by Country (2017-2022)
5.1.2 Americas Lanreotide Drugs Revenue by Country (2017-2022)
5.2 Americas Lanreotide Drugs Sales by Type
5.3 Americas Lanreotide Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lanreotide Drugs Sales by Region
6.1.1 APAC Lanreotide Drugs Sales by Region (2017-2022)
6.1.2 APAC Lanreotide Drugs Revenue by Region (2017-2022)
6.2 APAC Lanreotide Drugs Sales by Type
6.3 APAC Lanreotide Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lanreotide Drugs by Country
7.1.1 Europe Lanreotide Drugs Sales by Country (2017-2022)
7.1.2 Europe Lanreotide Drugs Revenue by Country (2017-2022)
7.2 Europe Lanreotide Drugs Sales by Type
7.3 Europe Lanreotide Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lanreotide Drugs by Country
8.1.1 Middle East & Africa Lanreotide Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lanreotide Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Lanreotide Drugs Sales by Type
8.3 Middle East & Africa Lanreotide Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lanreotide Drugs
10.3 Manufacturing Process Analysis of Lanreotide Drugs
10.4 Industry Chain Structure of Lanreotide Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lanreotide Drugs Distributors
11.3 Lanreotide Drugs Customer
12 World Forecast Review for Lanreotide Drugs by Geographic Region
12.1 Global Lanreotide Drugs Market Size Forecast by Region
12.1.1 Global Lanreotide Drugs Forecast by Region (2023-2028)
12.1.2 Global Lanreotide Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lanreotide Drugs Forecast by Type
12.7 Global Lanreotide Drugs Forecast by Application
13 Key Players Analysis
13.1 IPSEN
13.1.1 IPSEN Company Information
13.1.2 IPSEN Lanreotide Drugs Product Offered
13.1.3 IPSEN Lanreotide Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 IPSEN Main Business Overview
13.1.5 IPSEN Latest Developments
14 Research Findings and Conclusion
Table 1. Lanreotide Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lanreotide Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 60 mg
Table 4. Major Players of 90 mg
Table 5. Major Players of 120 mg
Table 6. Global Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Lanreotide Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Lanreotide Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Lanreotide Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Lanreotide Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Lanreotide Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Lanreotide Drugs Revenue by Application (2017-2022)
Table 14. Global Lanreotide Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Lanreotide Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Lanreotide Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Lanreotide Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Lanreotide Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Lanreotide Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Lanreotide Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Lanreotide Drugs Producing Area Distribution and Sales Area
Table 22. Players Lanreotide Drugs Products Offered
Table 23. Lanreotide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Lanreotide Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Lanreotide Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Lanreotide Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Lanreotide Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Lanreotide Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Lanreotide Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Lanreotide Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Lanreotide Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Lanreotide Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Lanreotide Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Lanreotide Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Lanreotide Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Lanreotide Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Lanreotide Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Lanreotide Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Lanreotide Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Lanreotide Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Lanreotide Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Lanreotide Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Lanreotide Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Lanreotide Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Lanreotide Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Lanreotide Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Lanreotide Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Lanreotide Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Lanreotide Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Lanreotide Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Lanreotide Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Lanreotide Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Lanreotide Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Lanreotide Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Lanreotide Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Lanreotide Drugs
Table 67. Key Market Challenges & Risks of Lanreotide Drugs
Table 68. Key Industry Trends of Lanreotide Drugs
Table 69. Lanreotide Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Lanreotide Drugs Distributors List
Table 72. Lanreotide Drugs Customer List
Table 73. Global Lanreotide Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Lanreotide Drugs Sales Market Forecast by Region
Table 75. Global Lanreotide Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Lanreotide Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Lanreotide Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Lanreotide Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Lanreotide Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Lanreotide Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Lanreotide Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Lanreotide Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Lanreotide Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Lanreotide Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Lanreotide Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Lanreotide Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Lanreotide Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Lanreotide Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Lanreotide Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Lanreotide Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Lanreotide Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Lanreotide Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. IPSEN Basic Information, Lanreotide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. IPSEN Lanreotide Drugs Product Offered
Table 95. IPSEN Lanreotide Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. IPSEN Main Business
Table 97. IPSEN Latest Developments
List of Figures
Figure 1. Picture of Lanreotide Drugs
Figure 2. Lanreotide Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lanreotide Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Lanreotide Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lanreotide Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 60 mg
Figure 10. Product Picture of 90 mg
Figure 11. Product Picture of 120 mg
Figure 12. Global Lanreotide Drugs Sales Market Share by Type in 2021
Figure 13. Global Lanreotide Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Lanreotide Drugs Consumed in Hospital
Figure 15. Global Lanreotide Drugs Market: Hospital (2017-2022) & (K Units)
Figure 16. Lanreotide Drugs Consumed in Pharmacy
Figure 17. Global Lanreotide Drugs Market: Pharmacy (2017-2022) & (K Units)
Figure 18. Global Lanreotide Drugs Sales Market Share by Application (2017-2022)
Figure 19. Global Lanreotide Drugs Revenue Market Share by Application in 2021
Figure 20. Lanreotide Drugs Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Lanreotide Drugs Revenue Market Share by Company in 2021
Figure 22. Global Lanreotide Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Lanreotide Drugs Revenue Market Share by Geographic Region in 2021
Figure 24. Global Lanreotide Drugs Sales Market Share by Region (2017-2022)
Figure 25. Global Lanreotide Drugs Revenue Market Share by Country/Region in 2021
Figure 26. Americas Lanreotide Drugs Sales 2017-2022 (K Units)
Figure 27. Americas Lanreotide Drugs Revenue 2017-2022 ($ Millions)
Figure 28. APAC Lanreotide Drugs Sales 2017-2022 (K Units)
Figure 29. APAC Lanreotide Drugs Revenue 2017-2022 ($ Millions)
Figure 30. Europe Lanreotide Drugs Sales 2017-2022 (K Units)
Figure 31. Europe Lanreotide Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Lanreotide Drugs Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Lanreotide Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Americas Lanreotide Drugs Sales Market Share by Country in 2021
Figure 35. Americas Lanreotide Drugs Revenue Market Share by Country in 2021
Figure 36. United States Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Lanreotide Drugs Sales Market Share by Region in 2021
Figure 41. APAC Lanreotide Drugs Revenue Market Share by Regions in 2021
Figure 42. China Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Lanreotide Drugs Sales Market Share by Country in 2021
Figure 49. Europe Lanreotide Drugs Revenue Market Share by Country in 2021
Figure 50. Germany Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Lanreotide Drugs Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Lanreotide Drugs Revenue Market Share by Country in 2021
Figure 57. Egypt Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Lanreotide Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Lanreotide Drugs in 2021
Figure 63. Manufacturing Process Analysis of Lanreotide Drugs
Figure 64. Industry Chain Structure of Lanreotide Drugs
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
